• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对恶性黑色素瘤高危患者进行筛查和监测可实现早期疾病的检测。

Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.

作者信息

Masri G D, Clark W H, Guerry D, Halpern A, Thompson C J, Elder D E

机构信息

Department of Medicine, Johns Hopkins Medical Institutions.

出版信息

J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1042-8. doi: 10.1016/0190-9622(90)70149-c.

DOI:10.1016/0190-9622(90)70149-c
PMID:2370329
Abstract

Screening, surveillance, and educational programs have been recommended for members of hereditary melanoma kindreds with dysplastic nevi, who are at very high risk for melanoma. For melanomas detected in a surveillance program offered to 555 such persons, the average thickness was 0.52 mm for 28 surveillance incident melanomas, 0.55 mm for 64 nonsurveillance incident melanomas, and 1.44 mm for 48 index lesions (p less than 0.001). The proportion of cases with level I or II invasion was 60.8%, 58.3%, and 36.2% respectively (p = 0.002). The nonsurveillance incident melanomas were diagnosed before entry into the surveillance program, but these patients were presumably aware of the earlier occurrence of two index melanomas in their families. These findings are consistent with a favorable effect of surveillance and education in a high-risk population and suggest that patient factors as well as physician factors may contribute to early diagnosis.

摘要

对于患有发育异常痣且患黑色素瘤风险极高的遗传性黑色素瘤家族成员,推荐进行筛查、监测和教育项目。在为555名此类人员提供的监测项目中检测到的黑色素瘤,28例监测期新发黑色素瘤的平均厚度为0.52毫米,64例非监测期新发黑色素瘤的平均厚度为0.55毫米,48例原发损害的平均厚度为1.44毫米(p<0.001)。I级或II级浸润病例的比例分别为60.8%、58.3%和36.2%(p = 0.002)。非监测期新发黑色素瘤是在进入监测项目之前被诊断出来的,但这些患者可能已经知晓其家族中早期出现过两例原发黑色素瘤。这些发现与监测和教育在高危人群中产生的良好效果一致,并表明患者因素以及医生因素可能有助于早期诊断。

相似文献

1
Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease.对恶性黑色素瘤高危患者进行筛查和监测可实现早期疾病的检测。
J Am Acad Dermatol. 1990 Jun;22(6 Pt 1):1042-8. doi: 10.1016/0190-9622(90)70149-c.
2
Monitoring of kindreds with hereditary predisposition for cutaneous melanoma and dysplastic nevus syndrome: results of a Swedish preventive program.对有皮肤黑素瘤和发育异常痣综合征遗传易感性的家族进行监测:一项瑞典预防计划的结果。
J Clin Oncol. 2007 Jul 1;25(19):2819-24. doi: 10.1200/JCO.2007.11.4108.
3
[Malignant melanoma--a warning. How to reduce mortality?].[恶性黑色素瘤——一则警示。如何降低死亡率?]
Tidsskr Nor Laegeforen. 1990 Apr 10;110(10):1202-5.
4
Multiple primary melanomas.多发性原发性黑色素瘤。
J Am Acad Dermatol. 2001 Jan;44(1):22-7. doi: 10.1067/mjd.2001.110878.
5
[Nevi, sun and the risk of melanoma].[痣、阳光与黑色素瘤风险]
Duodecim. 2002;118(4):359-66; quiz 366, 401.
6
Atypical mole syndrome: risk factor for cutaneous malignant melanoma and implications for management.非典型痣综合征:皮肤恶性黑色素瘤的危险因素及管理意义。
J Am Acad Dermatol. 1995 Mar;32(3):479-94. doi: 10.1016/0190-9622(95)90073-x.
7
Age at diagnosis and transmission of invasive melanoma in 23 families with cutaneous malignant melanoma/dysplastic nevi.23个患有皮肤恶性黑色素瘤/发育异常痣的家族中侵袭性黑色素瘤的诊断年龄及传播情况。
J Natl Cancer Inst. 1994 Sep 21;86(18):1385-90. doi: 10.1093/jnci/86.18.1385.
8
Dysplastic nevi. Markers for increased risk for melanoma.
Cancer. 1989 Jan 15;63(2):386-9. doi: 10.1002/1097-0142(19890115)63:2<386::aid-cncr2820630231>3.0.co;2-6.
9
Effectiveness and causes for failure of surveillance of CDKN2A-mutated melanoma families.CDKN2A 突变型黑色素瘤家族监测的有效性及失败原因。
J Am Acad Dermatol. 2011 Aug;65(2):289-296. doi: 10.1016/j.jaad.2010.06.067. Epub 2011 May 12.
10
Dysplastic nevus--a risk factor of developing skin melanoma clinical and epidemiological study with retrospective review of literature.
Med Pregl. 2011 May-Jun;64(5-6):315-8. doi: 10.2298/mpns1106315m.

引用本文的文献

1
Identifying high-risk melanoma patients: The importance of acquiring a detailed family history.识别高危黑色素瘤患者:获取详细家族病史的重要性。
J Eur Acad Dermatol Venereol. 2025 Mar 4. doi: 10.1111/jdv.20601.
2
Copper and Melanoma Risk: Results from NHANES 2007-2018 and Mendelian Randomization Analyses.铜与黑色素瘤风险:来自 NHANES 2007-2018 年和孟德尔随机分析的结果。
Biol Trace Elem Res. 2024 Nov;202(11):4909-4922. doi: 10.1007/s12011-024-04072-0. Epub 2024 Feb 20.
3
The importance of total-body photography and sequential digital dermatoscopy for monitoring patients at increased melanoma risk.
全身摄影和连续数字皮肤镜检查对监测高风险黑色素瘤患者的重要性。
J Dtsch Dermatol Ges. 2020 Jul;18(7):692-697. doi: 10.1111/ddg.14158. Epub 2020 Jun 29.
4
Targeted Melanoma Screening: Risk Self-Assessment and Skin Self-Examination Education Delivered During Mammography of Women.靶向黑色素瘤筛查:在女性乳房X光检查期间进行风险自我评估和皮肤自我检查教育
JNCI Cancer Spectr. 2019 Jun 28;3(3):pkz047. doi: 10.1093/jncics/pkz047. eCollection 2019 Sep.
5
A case of malignant melanoma after repeated recurrent dysplastic nevi.一例反复复发的发育异常痣后发生恶性黑色素瘤的病例。
Arch Craniofac Surg. 2019 Aug;20(4):260-264. doi: 10.7181/acfs.2019.00283. Epub 2019 Aug 20.
6
Li-Fraumeni syndrome: cancer risk assessment and clinical management.李-佛美尼综合征:癌症风险评估与临床管理。
Nat Rev Clin Oncol. 2014 May;11(5):260-71. doi: 10.1038/nrclinonc.2014.41. Epub 2014 Mar 18.
7
Management of melanoma families.黑素瘤家族的管理。
Cancers (Basel). 2010 Apr 16;2(2):549-66. doi: 10.3390/cancers2020549.
8
A melanoma risk score in a Brazilian population.巴西人群中的黑色素瘤风险评分
An Bras Dermatol. 2013 Mar-Apr;88(2):226-32. doi: 10.1590/S0365-05962013000200007.
9
Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.皮肤检查行为:黑色素瘤病史、皮肤类型、心理社会因素及居住地区在决定临床皮肤检查和自我皮肤检查中的作用
Arch Dermatol. 2012 Oct;148(10):1142-51. doi: 10.1001/archdermatol.2012.1817.
10
The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects.发育不良性痣:从历史角度到现代时代的管理:第一部分。历史、组织学和临床方面。
J Am Acad Dermatol. 2012 Jul;67(1):1.e1-16; quiz 17-8. doi: 10.1016/j.jaad.2012.02.047.